Comment
Author: Admin | 2025-04-28
10%): Headache, dizzinessVery rare (less than 0.01%): Paresthesia, somnolence, epileptic seizures, convulsionFrequency not reported: Grand mal seizure, taste disorder[Ref]Convulsions occurred in patients with renal dysfunction.[Ref]DermatologicUncommon (0.1% to 1%): Rash, pruritusRare (0.01% to 0.1%): Urticaria, angioneurotic edemaVery rare (less than 0.01%): Alopecia, severe skin reactions, toxic epidermal necrolysis, Stevens-Johnson syndrome, epidermal necrolysisFrequency not reported: Acne, dry skin, flushing[Ref]OtherUncommon (0.1% to 1%): FatigueFrequency not reported: Asthenia, fatigue, facial/orbital edema, tinnitus[Ref]MetabolicUncommon (0.1% to 1%): Loss of appetiteFrequency not reported: Anorexia[Ref]HematologicRare (0.01% to 0.1%): Thrombocytopenia, leukopenia, agranulocytosis, pancytopeniaFrequency not reported: Neutropenia[Ref]HepaticRare (0.01% to 0.1%): Intrahepatic cholestasis, jaundice, increased liver enzyme abnormalities (transaminases, gamma GT, alkaline phosphatase, bilirubin)Frequency not reported: Cholestatic jaundice, hepatitis[Ref]HypersensitivityRare (0.01% to 0.1%): Hypersensitivity reactions, anaphylaxis[Ref]RespiratoryRare (0.01% to 0.1%): BronchospasmFrequency not reported: Interstitial pneumonia[Ref]MusculoskeletalRare (0.01% to 0.1%): ArthralgiaVery rare (less than 0.01%): Muscle crampsFrequency not reported: Rhabdomyolysis, musculoskeletal pain[Ref]PsychiatricVery rare (less than 0.01%): Hallucinations, disorientation, confusion, anxiety, agitation, depression, reduced libido, insomniaFrequency not reported: Psychic disturbances[Ref]When patients obtained follow-up, psychic disturbances were found to be reversible.[Ref]CardiovascularVery rare (less than 0.01%): Chest tightness, prolonged QT intervalFrequency not reported: Arrhythmia, atrioventricular block, palpitation[Ref]QT interval prolongation occurred in patients with renal dysfunction.[Ref]GenitourinaryVery rare (less than 0.01%): Impotence[Ref]OcularFrequency not reported: Conjunctival injection[Ref]EndocrineFrequency not reported: Gynecomastia[Ref]References1. (2002) "Product Information. Pepcid (famotidine)." Merck & Co., Inc2. (2001) "Product Information. Pepcid AC (famotidine)." Johnson and Johnson/Merck3. Cerner Multum, Inc. "UK Summary of Product Characteristics."4. Cerner Multum, Inc. "Australian Product Information."Frequently asked questionsIs famotidine safer than omeprazole for heartburn?Can you take famotidine long term?Can I take omeprazole in the morning and famotidine at night?Further informationPepcid AC Chewable Tablets side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.Medical Disclaimer
Add Comment